鑻辨枃鍚嶇ū Anti-Bcl-6/5

涓枃鍚嶇ū 鍘熺檶鍩哄洜Bcl-6鎶楅珨

婵� 搴� 1mg/1ml

瑕�(gu墨) 鏍� 0.2ml/200渭g

鎶楅珨渚嗘簮 Rabbit

鍏嬮殕椤炲瀷 polyclonal

浜ゅ弶鍙嶆噳(y墨ng) Human, Mouse, Rat, Pig, Cow, Horse, Rabbit

鐢�(ch菐n)鍝侀鍨� 涓€鎶�

鐮旂┒闋�(l菒ng)鍩� 鑵槫 鍏嶇柅瀛�(xu茅) 淇¤櫉(h脿o)杞�(zhu菐n)灏�(d菐o) 绱�(x矛)鑳炲噵浜� 杞�(zhu菐n)閷勮(di脿o)绡€(ji茅)鍥犲瓙

铔嬬櫧鍒嗗瓙閲� predicted molecular weight: 78kDa

鎬� 鐙€ Lyophilized or Liquid

鍏� 鐤� 鍘� KLH conjugated synthetic peptide derived from humanBcl-6

浜� 鍨� IgG

绱斿寲鏂规硶 affinity purified by Protein A

鍎�(ch菙) 瀛� 娑� 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodiumazide

鐢�(ch菐n)鍝佹噳(y墨ng)鐢� WB=1:100-500 ELISA=1:500-1000 IP=1:20-100IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500

锛堢煶锠熷垏鐗囬渶鍋氭姉鍘熶慨寰�(f霉)锛�

not yet tested in other applications.

optimal dilutions/concentrations should be determined by theend user.

淇濆瓨姊濅欢 Store at -70 掳C for oneyear.

鍒� 鍚� B-cell lymphoma 6 protein isoform 1; zinc fingertranscription factor BCL6S; B-cell lymphoma 6 protein transcript; BCL-5; BCL-6;Bcl 6锛� protein LAZ-3; B-cell lymphoma 5 protein; zincfinger and BTB domain-containing protein 27; lymphoma-associated zinc fingergene on chromosome 3; zinc finger protein 51; cys-his2 zinc fingertranscription factor; BCL5; BCL6A; LAZ3; ZBTB27; ZNF51; BCL6_HUMAN.